Minneapolis, MN, United States of America

Darko Bosnakovski


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Darko Bosnakovski: Innovator in Cancer Treatment

Introduction

Darko Bosnakovski is a notable inventor based in Minneapolis, MN, who has made significant contributions to the field of cancer treatment. With a total of two patents to his name, he is dedicated to advancing medical science through innovative methods.

Latest Patents

Bosnakovski's latest patents focus on methods for treating cancer. One of his patents describes a method for treating cancer involving one or more translocations that generate an oncogenic fusion transcription factor requiring p300/CBP for activity in an animal. This method includes administering a compound of formula (I) or a pharmaceutically acceptable salt thereof to the animal. His work aims to provide new therapeutic options for patients suffering from cancer.

Career Highlights

Currently, Darko Bosnakovski is affiliated with the University of Minnesota, where he continues to research and develop innovative treatments. His work is characterized by a commitment to improving patient outcomes through scientific discovery and application.

Collaborations

Bosnakovski collaborates with fellow researcher Michael Kyba, enhancing the potential for groundbreaking advancements in cancer treatment through their combined expertise.

Conclusion

Darko Bosnakovski's contributions to cancer treatment through his innovative patents reflect his dedication to improving healthcare. His work at the University of Minnesota and collaborations with other researchers position him as a key figure in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…